8-Bromo-ATP is a purinergic P2X receptor agonist and exhibits cytotoxicity against multiple myeloma cells (IC50 = 23.1 μM); it is used in fluorescence measurements by selectively quenching certain tryptophan residues of ATPase; it enhances the dephosphorylation rate of native ATPase 2–3-fold in the absence of divalent cations.